newsfilter
← Latest News
Business Wire·

Sage Therapeutics Announces Strategic Reorganization to Prioritize ZURZUVAE® Commercialization and Focus its Development Portfolio

Planned workforce reduction of approximately 33% of employees expected to extend the company's cash runway Sage Therapeutics, Inc. (NASDAQ:SAGE), today announced a strategic reorganization of its business operations to